Moderna
-
Abington’s Katalin Karikó Inducted Into 2024 Class of Distinguished Daughters of Pennsylvania
Katalin Karikó, a Nobel Prize laureate, Penn professor, and renowned mRNA researcher from Abington, has been inducted into the 2024 Class of Distinguished Daughters of…
-
Carisma Therapeutics Selects First Drug Candidate Under Moderna Partnership, Triggers $2M Payment
Philadelphia-based Carisma Therapeutics has chosen an experimental cell therapy that targets the most prevalent type of liver cancer as the first drug development candidate under…
-
Penn Vet School, Nobel Prize Winner Dr. Drew Weissman, Collaborate On New mRNA Initiative
A new initiative has been launched at the University of Pennsylvania School of Veterinary Medicine to accelerate the development of mRNA-based vaccines and therapies for…
-
What Are the Keys to Philadelphia’s Status as One of America’s Fastest Rising Life Sciences City?
Philadelphia has gained great momentum in recent years as among the nation’s biggest life sciences markets, writes Jeff DeVuono for Brandywine Realty Trust. Over the…
-
Penn Medicine Biochemist Katalin Karikó Adds Award to Collection for mRNA Vaccine Breakthrough
Abington biochemist Katalin Karikó receives another award for her pioneering work in mRNA advancement, writes John George for the Philadelphia Business Journal. She was…
-
Penn Likely to Be Top Research Institution for Licensing Revenue, Thanks to Abington Resident
The University of Pennsylvania is likely to once again be on the top among U.S. research institutions for licensing revenue, thanks to COVID-19 vaccines lead…
Founding Partners
Advertisement
Affiliate Partners
